Playback speed
10 seconds
ASCO® GI 2024 Insights: "NRG-GI005 (COBRA) Study - ctDNA as a Predictive Biomarker in Adjuvant Chemo in Patients With Stage II Colon Cancer"
By
Insights from 2024 ASCO® GI Annual Meeting
FEATURING
Van Morris
By
Insights from 2024 ASCO® GI Annual Meeting
FEATURING
Van Morris
300 views
February 1, 2024
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY